Material from FiMVO info meeting for Marketing Authorisation Holders on Thursday 1st February 2018

On 1.2.18 we held a workshop for MAHs, and had a very successful day!

We discussed where we are with the medicine verification system in Finland, now that we have only one year to go!

Maija Gohlke-Kokkonen, FiMVO’s General Manager welcomed us all and spoke of contracting and fees.

Tero Vesa, FiMVO’s Technical Project Manager joined forces with Tim Stässer from Arvato to share the timeline of testing the Finnish project.

Paul Mills, from EMVO’S Operations Department brought to light the ways of the EU Hub and 3PLs, and answered many questions on the issue of inter market transactions.

Anna Ikonen from Bristol-Myers Sqibb talked about experiences of medicines verification in a pharma company, her key note being, act now! Time is running out!

FiMVO’s QA Teijo Yrjönen talked about quality in FiMVO operations.

Essi Kariaho, Director, Lääketietokeskus, discussed the move from NTINs to GTINs and the role of Vnrs in the future.

Johanna Linnolahti from The Finnish Medicines Agency rounded up the day with news from FIMEA. Thank you to everyone who participated, in person and by Skype,and thank you for all your positive feedback!

All material from the day is available here to download!